Error in Figure
In the original publication [1], there was a mistake in Figure 8 as published. Figure 8G–H was duplicated incorrectly in the proof version. The corrected Figure 8H appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 8.
Effect of PC-NE and PC-NE:GEM on apoptosis of MCF-7 and Hep-G2 cells, as was estimated with Annexin V-FITC-PI staining and flow cytometry. (A) MCF-7 control cells; (B) MCF-7 cells treated with 0.3 μM GEM; (C) MCF-7 cells treated with 0.3% v/v PC-NE; (D) MCF-7 cells treated with PC-NE:GEM (0.3% (v/v) + 0.3 μM); (E) Hep-G2 control cells; (F) Hep-G2 cells treated with 0.5 μM GEM; (G) Hep-G2 cells treated with 0.5% (v/v) PC-NE; (H) Hep-G2 cells treated with PC-NE:GEM (0.5% (v/v) + 0.5 μM). (I) Percentages of apoptosis (early plus late) in MCF-7 and Hep-G2 cells. The statistical differences were determined by independent sample t-test, one-way ANOVA, and Tukey’s post hoc test. The data are expressed as mean ± SEM (n = 3); *** p < 0.001; ns = not significant.
Reference
- AlMotwaa, S.M.; Al-Otaibi, W.A. Gemcitabine-Loaded Nanocarrier of Essential Oil from Pulicaria crispa: Preparation, Optimization, and In Vitro Evaluation of Anticancer Activity. Pharmaceutics 2022, 14, 1336. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).